These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 10869285

  • 21. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 22. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met.
    Onimaru Y, Tsukasaki K, Murata K, Imaizumi Y, Choi YL, Hasegawa H, Sugahara K, Yamada Y, Hayashi T, Nakashima M, Taguchi T, Mano H, Kamihira S, Tomonaga M.
    Int J Oncol; 2008 Oct 15; 33(4):697-703. PubMed ID: 18813782
    [Abstract] [Full Text] [Related]

  • 23. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
    Murakami M, Ikeda T, Saito T, Ogawa K, Nishino Y, Nakaya K, Funaba M.
    Cell Signal; 2006 Feb 15; 18(2):256-65. PubMed ID: 15961275
    [Abstract] [Full Text] [Related]

  • 24. Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells.
    Wu T, Han C, Lunz JG, Michalopoulos G, Shelhamer JH, Demetris AJ.
    Hepatology; 2002 Aug 15; 36(2):363-73. PubMed ID: 12143044
    [Abstract] [Full Text] [Related]

  • 25. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy.
    Sakamoto T, Liu Z, Murase N, Ezure T, Yokomuro S, Poli V, Demetris AJ.
    Hepatology; 1999 Feb 15; 29(2):403-11. PubMed ID: 9918916
    [Abstract] [Full Text] [Related]

  • 26. Hepatocyte growth factor stimulates DNA synthesis in alveolar epithelial type II cells in vitro.
    Shiratori M, Michalopoulos G, Shinozuka H, Singh G, Ogasawara H, Katyal SL.
    Am J Respir Cell Mol Biol; 1995 Feb 15; 12(2):171-80. PubMed ID: 7532419
    [Abstract] [Full Text] [Related]

  • 27. Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells.
    Welch WC, Kornblith PL, Michalopoulos GK, Petersen BE, Beedle A, Gollin SM, Goldfarb RH.
    Anticancer Res; 1999 Feb 15; 19(3A):1635-40. PubMed ID: 10470094
    [Abstract] [Full Text] [Related]

  • 28. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J, Dai C, Liu Y.
    J Am Soc Nephrol; 2005 Jan 15; 16(1):68-78. PubMed ID: 15537870
    [Abstract] [Full Text] [Related]

  • 29. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M.
    Cancer Res; 2000 Nov 01; 60(21):6148-59. PubMed ID: 11085539
    [Abstract] [Full Text] [Related]

  • 30. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H, Holt RU, Rø TB, Fagerli UM, Hjorth-Hansen H, Baykov V, Christensen JG, Waage A, Sundan A, Børset M.
    Clin Cancer Res; 2004 Oct 01; 10(19):6686-94. PubMed ID: 15475459
    [Abstract] [Full Text] [Related]

  • 31. Transforming growth factor beta receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells.
    Chattopadhyay N, T-Felt Hansen J, Godbole MM, Brown EM.
    Brain Res Mol Brain Res; 2004 Feb 05; 121(1-2):146-50. PubMed ID: 14969747
    [Abstract] [Full Text] [Related]

  • 32. Differential modulation of hepatocyte growth factor-stimulated motility by transforming growth factor beta1 on rat liver epithelial cells in vitro.
    Stolz DB, Michalopoulos GK.
    J Cell Physiol; 1998 Apr 05; 175(1):30-40. PubMed ID: 9491778
    [Abstract] [Full Text] [Related]

  • 33. Interleukin-6- and tumour necrosis factor alpha-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis.
    Khan KN, Masuzaki H, Fujishita A, Kitajima M, Hiraki K, Sekine I, Matsuyama T, Ishimaru T.
    Hum Reprod; 2005 Oct 05; 20(10):2715-23. PubMed ID: 16006475
    [Abstract] [Full Text] [Related]

  • 34. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T.
    Cancer Res; 2000 Dec 01; 60(23):6737-43. PubMed ID: 11118060
    [Abstract] [Full Text] [Related]

  • 35. Decreased fibronectin expression in Met/HGF-mediated tumorigenesis.
    Taylor GA, Jeffers M, Webb CP, Koo HM, Anver M, Sekiguchi K, Vande Woude GF.
    Oncogene; 1998 Sep 03; 17(9):1179-83. PubMed ID: 9764829
    [Abstract] [Full Text] [Related]

  • 36. Involvement of hepatocyte growth factor in branching morphogenesis of murine salivary gland.
    Ikari T, Hiraki A, Seki K, Sugiura T, Matsumoto K, Shirasuna K.
    Dev Dyn; 2003 Oct 03; 228(2):173-84. PubMed ID: 14517989
    [Abstract] [Full Text] [Related]

  • 37. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
    Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R.
    Cancer Res; 2006 Feb 01; 66(3):1721-9. PubMed ID: 16452232
    [Abstract] [Full Text] [Related]

  • 38. Neutrophils enhance invasion activity of human cholangiocellular carcinoma and hepatocellular carcinoma cells: an in vitro study.
    Imai Y, Kubota Y, Yamamoto S, Tsuji K, Shimatani M, Shibatani N, Takamido S, Matsushita M, Okazaki K.
    J Gastroenterol Hepatol; 2005 Feb 01; 20(2):287-93. PubMed ID: 15683434
    [Abstract] [Full Text] [Related]

  • 39. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
    Kawaguchi Y, Harigai M, Hara M, Fukasawa C, Takagi K, Tanaka M, Tanaka E, Nishimagi E, Kamatani N.
    J Rheumatol; 2002 Sep 01; 29(9):1877-83. PubMed ID: 12233882
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.